Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region - Global Forecast to 2030

The global smart pills market is experiencing significant growth in 2024, driven by the technological advancements in capsule endoscopy and the growing demand for non-invasive diagnostic monitoring devices. The market is projected to reach reach USD 1.30 billion by 2030 from USD 0.69 billion in 2024, at a CAGR of 11.2% during the forecast period. According to the American Cancer Society (ACS), in 2024, there were 1,52,810 new cases of colorectal cancer (CRC) comprising, 81,540 will be in men and 71,270 in women. Additionally, 1,06,590 of the cases will be colon cancer, while 46,220 will be rectal cancer. CRC remains the second leading cause of cancer-related deaths in the US with an estimated 53,010 deaths in 2024, showing a slight increase from last year’s projected 52,550. Thus, the high incidence of colon cancer are expected to increase the demand for capsule endoscopes for colon cancer screening.

“The small bowel tumor segment is projected to grow at the highest CAGR during the forecast period.”

Based on disease indication, the market for smart pills is divided into segments for crohn’s disease, small bowel tumors, occult GI bleeding, celiac disease, and other disease indications. The small bowel tumor is expected to grow at the highest CAGR during the forecast period due to factors, such as advancements in sensor technology, growing emphasis on patient convenience, rising need for early tumor diagnosis and proper treatment that are expected to drive the adoption of smart pills in the coming years.

“The large intestine accounted for the second largest share of the market during the forecast period in 2023, by target area. “

By target area, the smart pills market is broadly segmented into, small intestine, large intestine, esophagus, and stomach. In 2023, the large intestine target area accounted for the second largest share of smart pills market. Factors such as rising cases of colorectal cancer and requirement for applicable screening, diagnosis, and examining of inflammatory bowel diseases and other gastrointestinal diseases. The growing cases of colorectal cancer & colon cancer have contributed to the rising adoption of smart pills in large intestine as smart pills can reach areas of the colon that may be difficult to visualize with traditional methods.

By region, Europe hold the second largest share of the smart pills market in 2023

Europe accounted for the second largest share of the smart pills market in 2023. Factors such as increase in ageing population and improved utilization of capsule endoscopy for gastrointestinal (GI) bleeding are driving the European smart pills market. According to the guidelines of the European Society of Gastrointestinal Endoscopy (ESGE), small-bowel video capsule endoscopy is recommended as the initial examination for patients with unclear gastrointestinal bleeding. The endorsement of capsule endoscopy by the ESGE guidelines specifies a uniform approach for healthcare professionals, improving the quality of care provided to patients. As a result, the expanding demand for smart pills and other related technologies is driven by the growing use of capsule endoscopy for GI bleeding.

The break up of the profile of primary participants in the smart pills market:

• By Company Type: Tier 1- 40%, Tier 2- 35%, and Tier 25%
• By Designation: C-level Executives- 50%, Directors- 40% , and Others- 10%.
• By Region: North America- 45%, Europe- 30%, Asia Pacific- 20%, Latin America- 3%, and Middle East & Africa- 2%.

Key players in the Smart pills market

The key players operating in the smart pills market include Medtronic (US), Olympus Corporation (Japan), CapsoVision,Inc. (US), IntroMedic (South Korea), ANX Robotics (US), Shenzhen Jifu Medical Technology Co., Ltd. (China), JINSHAN Science & Technology (Group) (China), etectrx (US), Check-Cap (Israel), BodyCap (France) ,and Shangxian Minimal Invasive Inc (China).

Research Coverage:

The report analyzes the smart pills market and aims at estimating the market size and future growth potential of this market based on various segments such as application (capsule endoscopy,patient monitoring, and targeted drug delivery), target area (small intestine,large intestine, esophagus & stomach), disease indication (crohn’s disease, occult GI bleeding, small bowel tumor, celiac disease, & other disease conditions), end user (hospitals, diagnostic centers, outpatient settings, & other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The report also includes a product portfolio matrix of various smart pills products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

• Analysis of key drivers (rising demand for noninvasive diagnostic monitoring devices, technological advancements in capsule endoscopy, increasing incidence of colon cancer), restraints (high costs & technical limitations associated with accuracy of smart pills), opportunities (continuous innovation in sensor technology, wireless communication and rising need for rapid drug delivery development) and challenges (patient privacy concerns, shortage of skilled personnel).
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the smart pills market
• Market Development: Comprehensive information about lucrative markets – the report analyses the smart pills market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the smart pills market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of Medtronic (US), Olympus Corporation (Japan), CapsoVision,Inc. (US), IntroMedic (South Korea), ANX Robotics (US), Shenzhen jifu Medical Technology Co., Ltd. (China), JINSHAN Science & Technology (Group) (China), etectrx (US), Check-Cap (Israel), BodyCap (France) , and Shangxian Minimal Invasive Inc (China) in the smart pills market.

Tables List

Table 1 Smart Pills Market: Inclusions & Exclusions

Table 2 Smart Pills Market: Study Assumptions

Table 3 Smart Pills Market: Risk Analysis

Table 4 Smart Pills Market: Impact Analysis

Table 5 Sensor And Battery Types For Capsule Endoscopy Products

Table 6 Sensors Used For Vital Sign Monitoring Products

Table 7 Smart Pills Market: Drugs Under Pipeline

Table 8 Smart Pills Market: Porter’s Five Forces Analysis

Table 9 Influence Of Key Stakeholders On Buying Process, By Application (%)

Table 10 Key Buying Criteria For Smart Pills, By Application

Table 11 Tariff Data For Hs Code 901890

Table 12 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 13 Europe: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 14 Asia Pacific: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 15 Us Fda: Medical Device Classification

Table 16 Us: Medical Device Regulatory Approval Process

Table 17 Europe: Level Of Risk, Time, Cost, And Complexity Of

Registration Process

Table 18 Japan: Medical Devices Classification Under Pmda

Table 19 China: Classification Under Class I/Ii/Iii Medical Devices

Table 20 India: Level Of Risk, Time, Cost, And Complexity Of Registration Process

Table 21 Average Selling Price Of Capsule Endoscopes, By Key Player, 2023 (Usd)

Table 22 Average Selling Price Trend Of Capsule Endoscopes, By Region, 2020–2023 (Usd Per Unit)

Table 23 Case Study 1: Increased Imaging Capabilities For Patients With Small Bowel Abnormalities

Table 24 Case Study 2: Detection Of Gastric Polyp & Erythema Through Magnetically Controlled Capsule Endoscopes

Table 25 Case Study 3: Ai-assisted Capsule Endoscopy To Detect Obscure Gastrointestinal Bleeding In High-risk Cardiac Patients

Table 26 Smart Pills Market: List Of Key Patents, January 2020–december 2024

Table 27 Smart Pills Market: List Of Key Conferences & Events,

January 2025–december 2026

Table 28 Smart Pills Market: Unmet Needs

Table 29 Smart Pills Market: End-user Expectations

Table 30 Top 10 Importers For Hsn Code 901890, By Country,

2020−2023 (Usd Thousand)

Table 31 Top 10 Exporters For Hsn Code 901890, By Country,

2020−2023 (Usd Thousand)

Table 32 Case Study 1: Capsocam Sv-1 Versus Pillcam Sb3 To Detect Obscure Gastrointestinal Bleeding

Table 33 Case Study 2: Aardex Group Partnered With Etectrx, Inc. To Track Medication-taking Behaviors

Table 34 Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 35 Smart Pills Market For Small Intestine, By Region,

2022–2030 (Usd Million)

Table 36 Smart Pills Market For Large Intestine, By Region,

2022–2030 (Usd Million)

Table 37 Smart Pills Market For Esophagus, By Region, 2022–2030 (Usd Million)

Table 38 Smart Pills Market For Stomach, By Region, 2022–2030 (Usd Million)

Table 39 Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 40 Key Capsule Endoscopes Offered By Major Market Players

Table 41 Smart Pills Market For Capsule Endoscopy, By Region,

2022–2030 (Usd Million)

Table 42 Key Patient Monitoring Smart Pills Offered By Major Market Players

Table 43 Smart Pills Market For Patient Monitoring, By Region,

2022–2030 (Usd Million)

Table 44 Key Targeted Drug Delivery Smart Pills Under Pipeline

Table 45 Smart Pills Market For Targeted Drug Delivery, By Region,

2022–2030 (Usd Million)

Table 46 Smart Pills Market, By Disease Indication, 2022–2030 (Usd Million)

Table 47 Smart Pills Market For Occult Gastrointestinal Bleeding, By Region, 2022–2030 (Usd Million)

Table 48 Smart Pills Market For Crohn’s Disease, By Region,

2022–2030 (Usd Million)

Table 49 Smart Pills Market For Celiac Disease, By Region,

2022–2030 (Usd Million)

Table 50 Smart Pills Market For Small Bowel Tumors, By Region,

2022–2030 (Usd Million)

Table 51 Smart Pills Market For Other Disease Indications, By Region,

2022–2030 (Usd Million)

Table 52 Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 53 Smart Pills Market For Hospitals, By Region, 2022–2030 (Usd Million)

Table 54 Smart Pills Market For Diagnostic Centers, By Region,

2022–2030 (Usd Million)

Table 55 Smart Pills Market For Outpatient Settings, By Region,

2022–2030 (Usd Million)

Table 56 Smart Pills Market For Other End Users, By Region,

2022–2030 (Usd Million)

Table 57 Smart Pills Market, By Region, 2022–2030 (Usd Million)

Table 58 Smart Pills Market For Capsule Endoscopy, By Region,

2022–2030 (Thousand Units)

Table 59 Smart Pills Market For Patient Monitoring, By Region,

2022–2030 (Thousand Units)

Table 60 North America: Smart Pills Market, By Country,

2022–2030 (Usd Million)

Table 61 North America: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 62 North America: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 63 North America: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 64 North America: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 65 Us: Key Macroindicators

Table 66 Us: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 67 Us: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 68 Us: Smart Pills Market, By Disease Indication, 2022–2030 (Usd Million)

Table 69 Us: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 70 Canada: Key Macroindicators

Table 71 Canada: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 72 Canada: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 73 Canada: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 74 Canada: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 75 Europe: Smart Pills Market, By Country, 2022–2030 (Usd Million)

Table 76 Europe: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 77 Europe: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 78 Europe: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 79 Europe: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 80 Germany: Key Macroindicators

Table 81 Germany: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 82 Germany: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 83 Germany: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 84 Germany: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 85 Uk: Key Macroindicators

Table 86 Uk: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 87 Uk: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 88 Uk: Smart Pills Market, By Disease Indication, 2022–2030 (Usd Million)

Table 89 Uk: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 90 France: Key Macroindicators

Table 91 France: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 92 France: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 93 France: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 94 France: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 95 Italy: Key Macroindicators

Table 96 Italy: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 97 Italy: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 98 Italy: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 99 Italy: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 100 Spain: Key Macroindicators

Table 101 Spain: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 102 Spain: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 103 Spain: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 104 Spain: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 105 Rest Of Europe: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 106 Rest Of Europe: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 107 Rest Of Europe: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 108 Rest Of Europe: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 109 Asia Pacific: Smart Pills Market, By Country, 2022–2030 (Usd Million)

Table 110 Asia Pacific: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 111 Asia Pacific: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 112 Asia Pacific: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 113 Asia Pacific: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 114 Japan: Key Macroindicators

Table 115 Japan: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 116 Japan: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 117 Japan: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 118 Japan: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 119 China: Key Macroindicators

Table 120 China: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 121 China: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 122 China: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 123 China: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 124 India: Key Macroindicators

Table 125 India: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 126 India: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 127 India: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 128 India: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 129 Rest Of Asia Pacific: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 130 Rest Of Asia Pacific: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 131 Rest Of Asia Pacific: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 132 Rest Of Asia Pacific: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 133 Latin America: Smart Pills Market, By Country, 2022–2030 (Usd Million)

Table 134 Latin America: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 135 Latin America: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 136 Latin America: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 137 Latin America: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 138 Brazil: Key Macroindicators

Table 139 Brazil: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 140 Brazil: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 141 Brazil: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 142 Brazil: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 143 Mexico: Key Macroindicators

Table 144 Mexico: Smart Pills Market, By Target Area, 2022–2030 (Usd Million)

Table 145 Mexico: Smart Pills Market, By Application, 2022–2030 (Usd Million)

Table 146 Mexico: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 147 Mexico: Smart Pills Market, By End User, 2022–2030 (Usd Million)

Table 148 Rest Of Latin America: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 149 Rest Of Latin America: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 150 Rest Of Latin America: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 151 Rest Of Latin America: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 152 Middle East & Africa: Smart Pills Market, By Region,

2022–2030 (Usd Million)

Table 153 Middle East & Africa: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 154 Middle East & Africa: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 155 Middle East & Africa: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 156 Middle East & Africa: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 157 Gcc Countries: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 158 Gcc Countries: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 159 Gcc Countries: Smart Pills Market, By Disease Indication,

2022–2030 (Usd Million)

Table 160 Gcc Countries: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 161 Rest Of Middle East & Africa: Smart Pills Market, By Target Area,

2022–2030 (Usd Million)

Table 162 Rest Of Middle East & Africa: Smart Pills Market, By Application,

2022–2030 (Usd Million)

Table 163 Rest Of Middle East & Africa: Smart Pills Market, By Disease Indication, 2022–2030 (Usd Million)

Table 164 Rest Of Middle East & Africa: Smart Pills Market, By End User,

2022–2030 (Usd Million)

Table 165 Overview Of Strategies Deployed By Key Players In Smart Pills Market, January 2021–january 2025

Table 166 Smart Pills Market: Degree Of Competition

Table 167 Smart Pills Market: Region Footprint

Table 168 Smart Pills Market: Application Footprint

Table 169 Smart Pills Market: Target Area Footprint

Table 170 Smart Pills Market: Disease Indication Footprint

Table 171 Smart Pills Market: End-user Footprint

Table 172 Smart Pills Market: Region Footprint

Table 173 Smart Pills Market: Detailed List Of Key Startups/Sme Players

Table 174 Smart Pills Market: Competitive Benchmarking Of Key Startups/Sme Players

Table 175 Smart Pills Market: Product Launches, Approvals, And Enhancements, January 2021–january 2025

Table 176 Smart Pills Market: Deals, January 2021–january 2025

Table 177 Smart Pills Market: Other Developments, January 2021–january 2025

Table 178 Medtronic: Company Overview

Table 179 Medtronic: Products/Services/Solutions Offered

Table 180 Medtronic: Product Approvals & Enhancements,

January 2021–january 2025

Table 181 Medtronic: Deals, January 2021–january 2025

Table 182 Olympus Corporation: Company Overview

Table 183 Olympus Corporation: Products/Services/Solutions Offered

Table 184 Olympus Corporation: Other Developments,

January 2021–january 2025

Table 185 Capsovision, Inc.: Company Overview

Table 186 Capsovision, Inc.: Products/Services/Solutions Offered

Table 187 Capsovision, Inc.: Product Approvals & Enhancements, January 2021–january 2025

Table 188 Intromedic: Company Overview

Table 189 Intromedic: Products/Services/Solutions Offered

Table 190 Jinshan Science & Technology: Company Overview

Table 191 Jinshan Science & Technology: Products/Services/Solutions Offered

Table 192 Anx Robotics: Company Overview

Table 193 Anx Robotics: Products/Services/Solutions Offered

Table 194 Anx Robotics: Product Launches, Approvals, And Enhancements, January 2021–january 2025

Table 195 Shenzhen Jifu Medical Technology Co., Ltd.: Company Overview

Table 196 Shenzhen Jifu Medical Technology Co., Ltd.: Products/Services/ Solutions Offered

Table 197 Etectrx: Company Overview

Table 198 Etectrx: Products/Services/Solutions Offered

Table 199 Etectrx: Product Enhancements, January 2021–january 2025

Table 200 Etectrx: Deals, January 2021–january 2025

Table 201 Bodycap: Company Overview

Table 202 Bodycap: Products/Services/Solutions Offered

Table 203 Bodycap: Product Launches, January 2021–january 2025

Table 204 Bodycap: Deals, January 2021–january 2025

Table 205 Check-cap: Company Overview

Table 206 Check-cap: Products/Services/Solutions Offered

Table 207 Check-cap: Product Approvals, January 2021–january 2025

Table 208 Check-cap: Expansions, January 2021–january 2025

Table 209 Shangxian Minimal Invasive Inc.: Company Overview

Table 210 Shangxian Minimal Invasive Inc.: Products/Services/Solutions Offered

Table 211 Veloce Corporation: Company Overview

Table 212 Biocam: Company Overview

Table 213 Endiatx: Company Overview

Table 214 Rf Co., Ltd.: Company Overview

Table 215 Celero Systems: Company Overview

Table 216 Biora Therapeutics, Inc.: Company Overview

Table 217 Innurvation: Company Overview

Table 218 Rani Therapeutics: Company Overview

Table 219 Motilis Medica Sa: Company Overview

Figures List

Figure 1 Smart Pills Market Segmentation & Geographical Spread

Figure 2 Smart Pills Market: Years Considered

Figure 3 Smart Pills Market: Research Design

Figure 4 Smart Pills Market: Key Data From Secondary Sources

Figure 5 Smart Pills Market: Key Primary Sources

Figure 6 Smart Pills Market: Key Data From Primary Sources

Figure 7 Smart Pills Market: Insights From Key Primaries

Figure 8 Breakdown Of Primary Experts: By Company Type,

Designation, And Region

Figure 9 Market Size Estimation: Supply-side Analysis

Figure 10 Smart Pills Market: Bottom-up Approach (Demand-side Analysis)

Figure 11 Smart Pills Market: Top-down Approach

Figure 12 Smart Pills Market: Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges (2024–2030)

Figure 13 Smart Pills Market: Cagr Projections (Supply Side)

Figure 14 Smart Pills Market: Data Triangulation

Figure 15 Smart Pills Market, By Application, 2024 Vs. 2030 (Usd Million)

Figure 16 Smart Pills Market, By Target Area, 2024 Vs. 2030 (Usd Million)

Figure 17 Smart Pills Market, By Disease Indication, 2024 Vs. 2030 (Usd Million)

Figure 18 Smart Pills Market, By End User, 2024 Vs. 2030 (Usd Million)

Figure 19 Regional Snapshot Of Smart Pills Market

Figure 20 Increasing Adoption Of Capsule Endoscopy In Emerging

Economies To Fuel Uptake Of Smart Pills

Figure 21 Us And Capsule Endoscopy Segments Dominated North American Smart Pills Market In 2023

Figure 22 China To Register Highest Growth Rate From 2024 To 2030

Figure 23 Asia Pacific To Grow At Highest Cagr During Forecast Period

Figure 24 Emerging Markets To Register Highest

Growth Rate During Study Period

Figure 25 Smart Pills Market: Drivers, Restraints, Opportunities, And Challenges

Figure 26 Healthcare Security Breaches Of 500 + Records, 2009–2024

Figure 27 Smart Pills Market: Trends/Disruptions Impacting Customer’s Business

Figure 28 Smart Pills Market: Porter’s Five Forces Analysis

Figure 29 Influence Of Key Stakeholders On Buying Process, By Application

Figure 30 Key Buying Criteria For Smart Pills, By Application

Figure 31 Smart Pills Market: Ecosystem Analysis

Figure 32 Smart Pills Market: Value Chain Analysis

Figure 33 Average Selling Price Of Smart Pills, By Key Player (2023)

Figure 34 Smart Pills Market: Global Patent Publication Trends (2015–2024)

Figure 35 Top Applicants (Companies/Institutions) For Smart Pill Patents (January 2014–december 2024)

Figure 36 Top Applicants For Smart Pill Patents (Country/Region)

(January 2014–december 2024)

Figure 37 Smart Pills Market: Funding And Number Of Deals (2020–2024)

Figure 38 Market Potential Of Ai/Gen Ai On Smart Pills Across Industries

Figure 39 Impact Of Ai/Gen Ai On Interconnected And Adjacent Ecosystems

Figure 40 North America: Smart Pills Market Snapshot

Figure 41 Asia Pacific: Smart Pills Market Snapshot

Figure 42 Revenue Analysis Of Key Players In Smart Pills Market,

2019–2023 (Usd Million)

Figure 43 Market Share Analysis Of Key Players In Smart Pills Market (2023)

Figure 44 Smart Pills Market: Company Evaluation Matrix (Key Players), 2023

Figure 45 Smart Pills Market: Company Footprint

Figure 46 Smart Pills Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 47 Ev/Ebitda Of Key Vendors

Figure 48 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta

Of Key Vendors

Figure 49 Smart Pills Market: Brand/Product Comparative Analysis

Figure 50 Medtronic: Company Snapshot

Figure 51 Olympus Corporation: Company Snapshot